Article Details
Retrieved on: 2021-05-17 11:03:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The company is also developing two monoclonal antibodies, CERC-002, and CERC-007. CERC-002 targets the cytokine LIGHT (TNFSF14) and is in ...
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here